Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, 130117, Jilin, China.
College of Pharmacy, Changchun University of Chinese Medicine, Changchun, 130117, Jilin, China.
J Orthop Surg Res. 2020 Apr 15;15(1):146. doi: 10.1186/s13018-020-01677-8.
Guzhi Zengsheng Zhitongwan (GZZSZTW) is an effective Chinese medicinal formulation for the treatment of osteoarthritis (OA) designed according to the "kidney governing bone" theory, which has been widely used as a golden guide for treating bone and cartilage diseases in traditional Chinese medicine. The aim of this study was to explore the molecular mechanism underlying its effects on the bone and kidney.
Preparation and quality control were performed as previously described. Since GZZSZTW is orally administered in the form of pills prepared in boiled water, the Chinese materia medica (CMM) mixture of this formula was extracted with distilled water by a reflux method and was then filtered through a 0.45-μm Hollow Fiber Cartridge (GE Healthcare, USA). The filtrate was freeze-dried by a Heto PowerDry LL3000 Freeze Dryer (Thermo, USA) and stored at - 80 °C. The effects of GZZSZTW on gene expression and regulation of both kidney and bone tissues were investigated using a state-of-the-art RNA-seq technology.
We demonstrated that GZZSZTW could enhance kidney function and suppress bone formation and resorption by modulating the activities of osteoblast and osteoclast, and might subsequently contribute to the inhibition of osteophyte formation during the process of OA. These effects might be achieved by the synergistic interactions of various herbs and their active components in GZZSZTW, which increased the expression levels of functional genes participating in kidney function, regulation, and repair, and then decreased the expression levels of genes involved in bone formation and resorption. Thus, our findings were consistent with the "kidney governing bone" theory, which has been widely used as a guide in clinical practice for thousands of years.
This study has deepened the current knowledge about the molecular effects of GZZSZTW on bone and kidney regulation. Furthermore, this study might be able to provide possible strategies to further prevent and treat joint diseases by using traditional Chinese medicinal formulations following the "kidney governing bone" theory.
骨治增生止痛丸(GZZSZTW)是一种根据“肾主骨”理论设计的治疗骨关节炎(OA)的有效中药配方,被广泛用作中医治疗骨与软骨疾病的金标准。本研究旨在探讨其对骨骼和肾脏作用的分子机制。
按以前的描述进行制备和质量控制。由于 GZZSZTW 以水丸的形式口服给药,用回流法用蒸馏水提取该配方的中药混合物,然后用 0.45-μm 中空纤维过滤器(GE Healthcare,美国)过滤。滤液用 Heto PowerDry LL3000 冷冻干燥机(Thermo,美国)冷冻干燥并储存在-80°C。使用最先进的 RNA-seq 技术研究 GZZSZTW 对基因表达的影响和对肾脏和骨骼组织的调节作用。
我们证明,GZZSZTW 通过调节成骨细胞和破骨细胞的活性,增强肾功能,抑制骨形成和吸收,随后可能有助于抑制 OA 过程中的骨赘形成。这些作用可能是由 GZZSZTW 中的各种草药及其活性成分的协同作用实现的,它增加了参与肾功能、调节和修复的功能性基因的表达水平,然后降低了参与骨形成和吸收的基因的表达水平。因此,我们的发现与“肾主骨”理论一致,该理论已被广泛用作临床实践数千年来的指导原则。
本研究加深了我们对 GZZSZTW 对骨骼和肾脏调节的分子作用的认识。此外,本研究可能能够提供可能的策略,通过使用基于“肾主骨”理论的中药配方,进一步预防和治疗关节疾病。